Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01056848 · ClinicalTrials.gov registry record
International, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatremia: Extension to Studies CK-LX3401, 3405, and 3430
A clinical trial, sponsored by CardioKine.
- Completed
- Registry status
- 135
- Enrollment target
NCT01056848 is a clinical trial that has completed, run by CardioKine. The registered enrollment target is 135 participants.
The verdict
NCT01056848 has completed, sponsored by CardioKine.
- COMPLETED
- Registry status
- 135 participants
- Enrollment target
Study Summary
To evaluate the overall safety and continued efficacy of oral lixivaptan capsules in subjects with euvolemic and hypervolemic hyponatremia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2010-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01056848
The ClinicalTrials.gov registry entry for NCT01056848 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CardioKine, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01056848 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01056848 about?
NCT01056848 is a clinical study titled "International, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatremia: Extension to Studies CK-LX3401, 3405, and 3430". To evaluate the overall safety and continued efficacy of oral lixivaptan capsules in subjects with euvolemic and hypervolemic hyponatremia
What is the current status of trial NCT01056848?
This trial is currently completed. The enrollment target is 135 participants. The study started on 2010-01.
Who is sponsoring clinical trial NCT01056848?
This trial is sponsored by CardioKine, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.